UNDATED - Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...

ISMP has long endorsed the use of unit dose syringes of injectable drugs, including Carpujects, as a safe practice. If Carpuject cartridges are stocked in patient care units, to ensure proper use ISMP ...

Hospira announced a nationwide voluntary recall of one lot of Morphine Sulfate injection, 4mg/mL, due to a customer report of two Carpujects syringes containing more than the 1mL labeled fill volume.

Knoxville — An Anderson County emergency responder has some supplies from a Naloxone maker now facing a voluntary product recall. Anderson County EMS tells 10News it has used some of the drug that ...

The problems with overfilled Hospira Carpuject syringes is far more extensive than first suspected, but instead of ordering a recall, which would create some immediate shortages, the FDA is leaning on ...

WASHINGTON (CN) - Some Hospira Carpuject pre-filled syringe cartridges contain extra medication, which may produce an overdose, according to a Food and Drug Administration press release. Pharmacies ...

According to the FDA, Hospira, Inc., a Pfizer company is recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...

An investigation into user complaints of overfilled Carpuject syringes led Hospira ($HSP) to realize manufacturing problems with overfills were far more extensive ...

GLOVERSVILLE—Officials say the recall of an opioid overdose reversal medication announced this week will not impact the ability of emergency responders or hospitals to treat overdose victims locally.

On May 18, 2012, Hospira issued a safety alert to healthcare professionals about potential, clinically significant volume overfill in prefilled Carpuject and iSecure syringe systems—more than twice ...